Gimple etc. analyzed 10 glioblastoma specimens obtained via surgical resection and 15 non-neoplastic brain tissue samples through chromatin immunoprecipitation sequencing (ChIP-seq), and screened out the genes WSCD1, ELOVL2 and KLHDC8A that are regulated by glioma stem cell (GSC)-related enhancers, providing new targets for the treatment of gliomas (47) (Figure 3). The gene discussed is ELOVL2; the disease is glioma.